PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA FOLLOWING TREATMENT WITH HIGH-DOSE METHOTREXATE

被引：0
|
作者：
Cappelli, Louis [1 ]
Newman, Jennifer [1 ]
Sharif, Muhammad [1 ]
Kayne, Allison [1 ]
Epperla, Narendranath [2 ]
Elguindy, Ahmed [2 ]
Palmer, Joshua [3 ]
Alnahhas, Iyad [1 ]
Shi, Wenyin [1 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, James Canc Hosp, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NCOG-40
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: HIGH-DOSE METHOTREXATE PLUS RADIOTHERAPY, BETTER TREATMENT FOR ALL?
    Gonzalez-Domingo, M.
    Gonzalez-San Segundo, C.
    Menarguez, J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : X - X
  • [32] A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
    Villanueva, Gabriela
    Guscott, Martin
    Schaiquevich, Paula
    Sampor, Claudia
    Combs, Ryan
    Tentoni, Nicolas
    Hwang, Miriam
    Lowe, Jennifer
    Howard, Scott
    CANCERS, 2023, 15 (05)
  • [33] Outcome after high-dose methotrexate and radiotherapy for primary central nervous system lymphoma
    Choi, J. H.
    Kim, I. H.
    Heo, D. S.
    Jung, H. W.
    EJC SUPPLEMENTS, 2009, 7 (02): : 501 - 501
  • [34] High-dose methotrexate and zanubrutinib combination therapy for primary central nervous system lymphoma
    Yadav, Budhi Singh
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (03):
  • [35] Leukocytoclastic Vasculitis and Desensitization to High-dose Methotrexate in Primary Central Nervous System Lymphoma
    Hanna, Colette
    Villa, Diego
    Irani, Carla
    Ghosn, Marwan
    El Rassy, Elie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (05): : E197 - E200
  • [36] Outcome after High-dose Methotrexate and Radiotherapy in Primary Central Nervous System Lymphoma
    Choi, J.
    Kim, I.
    Heo, D.
    Jung, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S254 - S254
  • [37] Risk factors for high-dose methotrexate associated toxicities in patients with primary central nervous system lymphoma
    Sun, Kai
    Tao, Hongwei
    Ding, Tianling
    Li, Ziran
    Qiu, Xiaoyan
    Zhong, Mingkang
    Wu, Zhuo
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (12) : 2196 - 2204
  • [38] High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma
    Holdhoff, Matthias
    Ambady, Prakash
    Abdelaziz, Ahmed
    Sarai, Guneet
    Bonekamp, David
    Blakeley, Jaishri
    Grossman, Stuart A.
    Ye, Xiaobu
    NEUROLOGY, 2014, 83 (03) : 235 - 239
  • [39] HIGH-DOSE METHOTREXATE WITH OR WITHOUT RITUXIMAB IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA
    Chamberlain, Marc C.
    NEUROLOGY, 2015, 84 (07) : 758 - 759
  • [40] High-Dose Methotrexate, Ibrutinib and Temozolomide (MIT) for the Treatment of Newly Diagnosed Primary Central Nervous System Lymphoma: A Multi-Center Prospective Phase II Study
    Ping, Liqin
    Wang, Xiaoxiao
    Gao, Yan
    Bai, Bing
    Huang, He
    Cai, Linbo
    Zhou, Hui
    Shan, Changguo
    Li, Zhiming
    Lai, Mingyao
    He, Haixia
    Huang, Cheng
    Chen, Haoqing
    Feng, Ru
    Huang, Huiqiang
    BLOOD, 2023, 142
12345